1. Dr. Dean Fennell. Mesothelioma treatment expert. Biography. 0
Dr. Dean Fennell, MD, explains his extensive background in cancer research. He is a Professor of Thoracic Medical Oncology at the University of Leicester.
▶⏸
2. Mesothelioma symptoms. Causes of Mesothelioma. 1
Dr. Dean Fennell, MD, explains the causes, symptoms, and diagnosis of this rare cancer. Mesothelioma is a cancer of the lining of the chest or...
▶⏸
3. Genetic mutations in mesothelioma. Is early diagnosis of mesothelioma possible? 2
Dr. Dean Fennell, MD, explains the unique molecular signature of this aggressive cancer. He details the three most common genetic alterations found in mesothelioma patients....
Dr. Dean Fennell, MD, explains how diagnostic tests guide treatment selection. Histology is critical for prognosis and therapy decisions. Epithelial mesothelioma has a better outcome...
▶⏸
5. Mesothelioma. Surgical treatment options. 4
Dr. Dean Fennell, MD, explains the complex role of surgery in treating this aggressive cancer. He details how patient selection is critical, as some mesothelioma...
▶⏸
6. Мезотелиома. Лучевая терапия. 5
Dr. Dean Fennell, MD, explains the role of radiotherapy in treating this aggressive cancer. He details the findings of key clinical trials that have shaped...
▶⏸
7. Мезотелиома. Химиотерапия и иммунотерапия. 6
Dr. Dean Fennell, MD, explains the evolution of systemic therapy for this aggressive cancer. He details the historical standard of pemetrexed with platinum chemotherapy.
Dr. Dean Fennell, MD, explains the latest treatment advances. He discusses the potential of CAR T-cell therapy targeting mesothelin.
▶⏸
9. Клинические исследования стратифицированной терапии мезотелиомы (КИСТМ). 8
Dr. Dean Fennell, MD, explains the innovative Mesothelioma Stratified Therapy (MiST) clinical trial program. This master protocol tests multiple targeted treatments simultaneously in biomarker-selected patient...
▶⏸
10. Перспективы лечения мезотелиомы. 9
Dr. Dean Fennell, MD, explains the future of systemic therapy for this aggressive cancer. He highlights the increasing pace of drug development and the discovery...
▶⏸
11. Мезотелиома. Роль участия пациентов в клинических исследованиях. 10
Dr. Dean Fennell, MD, explains the critical importance of clinical trials for patients. He addresses common patient questions about prognosis and survival.
▶⏸
12. Мезотелиома. Клинический случай. Пример значимости участия в клинических исследованиях. 11
Dr. Dean Fennell, MD, explains the critical importance of clinical trials for advanced treatment. He shares a compelling clinical case where a novel PARP inhibitor...
Уточните план лечения, проконсультировавшись с ведущими специалистами, которые полностью соответствуют вашему клиническому случаю.
